About Thomson Reuters IPD
Thomson Reuters IPD has been a pioneer in the development of globally respected epidemiology databases and provides a full range of primary market research services, with an exclusive focus on the healthcare industry. Our clients include academic institutions, governmental agencies, biopharmaceutical companies, device manufacturers, and other types of organizations dedicated to making a positive impact in healthcare. For more than 20 years, Thomson Reuters IPD has been dedicated to the highest standards of quality and data accuracy.
Thomson Reuters IPD exists to provide accurate, high quality epidemiological and market research data that enable and encourage our clients to develop healthcare products and services that make a positive difference in the lives of individual patients.
Thomson Reuters IPD is committed to being a recognized, full-service leader in healthcare epidemiology and market research by offering high quality products, outstanding services, and strategic pricing, resulting in delivery of greater value than our competition. The company strives to incorporate the latest technology in database and market research.